EOFY Sale · Save up to $750 off your legals · Ends 30 June

Claim offer
Selected cases

Federal Court of Australia Full Court · [2026] FCAFC 72

Nalco v Cytec patent amendments

A Full Federal Court patent decision about claim construction, support, sufficient disclosure and whether amended patent claims could...

Federal Court of Australia Full Court26 May 2026

Plain-English explainers, not legal advice. Check the linked official source before you rely on a specific section, and get advice for your situation.

Get legal help

Start here

Quick read

  • Patent value depends on the fit between the invention, the specification, the claims and any amendment strategy.
  • A Full Federal Court patent decision about claim construction, support, sufficient disclosure and whether amended patent claims could proceed to grant.

Use this to check

  • Patent claims need to match the technical contribution disclosed in the specification.
  • Opposition proceedings can test support, sufficient disclosure, novelty and inventive step before grant.
  • Amendment strategy can matter during a Court appeal, not only before the Patent Office.

Decision snapshot

  1. 1

    What happened

    • Nalco Company applied for Australian patent application no 2012220990, titled Reducing aluminosilicate scale in the Bayer process, with a priority date of 25 February 2011.
    • The application concerned silane-based small molecules used to reduce scale in Bayer process streams.
    • Cytec Industries opposed grant of the patent application, including on novelty, inventive step, sufficiency and support grounds.
    • A delegate of the Commissioner of Patents found problems with sufficient disclosure, support, clarity and some novelty issues.
  2. 2

    What the court had to decide

    • The Full Court had to decide whether leave to appeal should be granted, whether the primary judge was right to uphold Cytec's opposition on sufficient disclosure and support grounds for the earlier claims, and whether Nalco's proposed amendments to Australian patent application no 2012220990 were allowable and should be granted under the Patents Act.
  3. 3

    What the court decided

    • The Full Court granted leave to appeal.
    • It dismissed Nalco's appeal from the principal decision, but allowed the appeal from the amendment decision.
    • The Court set aside the orders refusing the amendment application, granted Nalco's amended interlocutory application and ordered that Australian patent application no 2012220990 proceed to grant in amended form, subject to a 28 day stay and further costs submissions.

Practical impact

Practical read

  • Patent value depends on the fit between the invention, the specification, the claims and any amendment strategy.
  • R&D businesses should involve patent advisers early enough to make the technical contribution clear before opposition or appeal forces a narrower path.

Useful next steps

  • Patent claims need to match the technical contribution disclosed in the specification.
  • Opposition proceedings can test support, sufficient disclosure, novelty and inventive step before grant.
  • Amendment strategy can matter during a Court appeal, not only before the Patent Office.
  • A technically valuable invention can still face serious risk if the claim language is too broad or unclear.
  • R&D businesses should keep lab evidence, examples, claim strategy and commercial use cases aligned.

Practical read

This is a specialist patent case, but the business lesson is easy to understand. Nalco had a technical invention in an industrial process. Cytec opposed the patent. The fight became about whether the claims matched what the patent specification actually taught, and whether amendments could fix the problems identified along the way.

The Full Court did not simply rescue the original patent position. Nalco lost the appeal on the principal decision about the earlier claims. But it won on the amendment application. The majority held that the Court could deal with amendments during the appeal process and that the amended form should proceed to grant. Justice Jackson agreed on leave and the principal appeal, but would have dismissed the amendment appeal too. That split itself shows how exacting patent claim language can be.

For R&D businesses, the practical point is to think about patents as evidence documents, not just registration assets. The specification has to disclose the invention clearly enough and support the claims. If the product or process is technically complex, claim wording, examples, expert evidence and amendment options all matter. A patent that is too broad, unclear or poorly aligned with the technical contribution can become expensive to defend before it ever becomes a useful commercial asset.

Checks to run

Key points

  • Before filing, check that the specification teaches the invention across the full claimed area.
  • Document experiments, examples and technical assumptions in a way a patent adviser can use.
  • Review whether claim language covers what the business actually needs to commercialise.
  • If an opposition identifies problems, assess amendment options early rather than treating them as an afterthought.
  • Keep patent strategy connected to product, licensing, investor and competitor-risk planning.

Key takeaways

  • Patent claims need to match the technical contribution disclosed in the specification.
  • Opposition proceedings can test support, sufficient disclosure, novelty and inventive step before grant.
  • Amendment strategy can matter during a Court appeal, not only before the Patent Office.
  • A technically valuable invention can still face serious risk if the claim language is too broad or unclear.
  • R&D businesses should keep lab evidence, examples, claim strategy and commercial use cases aligned.

Related topics

How Sprintlaw can help